The Belgian pharmaceutical conference

THE ANNUAL NETWORKING
PLACE TO BE

April 17, 2012 Dolce La Hulpe Brussels — The Impatient Patient © CLICK HERE TO REGISTER

  • Home
  • Program
  • Speakers
  • Partners
  • Venue
  • Practical
  • Press

running order

08:00 - 09:30

Welcome Coffee - Exhibition Lounge

09:30 – 09:45

Grand Opening - Plenary Room
Laurette Onkelinx - Minister of Public Health and Social Affairs

09:45 – 10:45

"The Impatient Patient" - Plenary Room

Chair: Dr. Jo De Cock (General administrator National Institute of Health & Disability Insurance)

"Belgium's Patient Movement: Size and Scope" - Dr. Alexandra Wyke (Founder and CEO PatientView)

"Valuing Patient Involvement - A European Perspective" - Nicola Bedlington (Executive Director European Patients’ Forum)

10:45 – 11:15

Coffee break - Exhibition Lounge

11:15 – 12:30

The Initiative to Promote Clinical Trials in Belgium – Plenary Room

Chair : Dr. Greet Musch (General Director DG Pre-authorisation FAMHP)

  • "Clinical Trials with Medical Devices" - David Bouchez (Clinical Program Manager Stentys, Consultant UNAMEC)
  • "The Strategic Plan to Promote Clinical Trials in Belgium" - Ingrid Maes (Director Strategy & Operations Pharma & Healthcare PwC Belgium)

12:30 - 14:00

Lunch - Exhibition Lounge

14:00 - 16:00

Break-out parallel sessions

Patient Access to Medicines - BEAPP

Chair: Dr. Stefaan Vancayzeele (Vice-Chair BeAPP, CSO Novartis)

  • "Clinical inertia, a major concern in drug therapy" - Prof. Dr. André Scheen (Head of the Division of Diabetes, Nutrition & Metabolic Disorders and of the Clinical Pharmacology Unit, CHU Liège)
  • "Early access and market authorization" - Dr. Greet Musch (General Director DG Pre-authorisation FAMHP)
  • "Unmet medical need and early access" - Dr. Ri De Ridder (Director General National Institute of Health & Disability Insurance)

Assessment of Medicines - pharma.be I

Chair : Richard Bergström (Director General EFPIA)

  • "Scope of Health Technology Assessment: the 5y Perspective" - Prof. Dr. Bruno Flamion (Professor of Physiology and Pharmacology, University of Namur, Belgium, EMA, chairman CTG/CRM)
  • "The progresses of WP5 and the objectives of the Working Group within the frame of the second Joint Action" - Sarah Kleijnen (Project Coordinator EUnetHTA WP5, College voor Zorgverzekeringen (CVZ))

Innovation in early clinical drug development – BAPU

Chair : Prof. Dr. Jan de Hoon (Head of the Center for Clinical Pharmacology (KULeuven/UZ Leuven), Chairman Belgian Association of Phase I Units (BAPU)) – Dr. Maikel Raghoebar (Senior Director, Head Clinical Pharmacology Unit Janssen in Belgium and Vice-Chair BAPU)

  • "Welcome and introduction" - Dr. Maikel Raghoebar (Senior Director, Head Clinical Pharmacology Unit Janssen in Belgium and Vice-Chair BAPU)
  • "Is there a need for a European registration system for subjects participating in clinical trials ?" - Annick Peremans (General Manager Research Centre Aalst, Belgium)

Mini-Symposium – "Imaging techniques as innovative biomarkers in the exploratory phase of clinical drug development"

  • "Biomarkers : what’s in a name?" - Prof. Dr. Jan de Hoon
  • "PET: a primary exploratory technology in rational drug development?" - Prof. Dr. Koen Van Laere (Clinical Head and University professor KULeuven)
  • "Added value of functional MRI (fMRI)" - Prof. Dr. Rik Achten
  • "Hybrid SPECT/CT imaging: the perfect marriage to explore new horizons" - Dr. Pieter De Bondt (Head Division Nuclear Medicine, OLV Hospital, Aalst)

Patient Involvement in Policy Making - pharma.be II

Chair : Xavier De Cuyper (CEO FAMHP)

  • "Patient involvement: a new challenge for the industry" - Magali Geens (Research Director InSites Consulting)
  • "Patient Involvement improves Health Care Policy Outcomes" - Dr. Markus Breuer (Head of Education Institute Dialogue Ethics – Interdisciplinary Institute for ethics in health care in Zurich (CH))

16:00 - 16:45

Coffee break - Exhibition Lounge

16:45 – 18:00

pharma / health care and the ECONOSHOCK - Plenary Room

Chair : Tom Heyman (CEO Janssen Pharmaceutica N.V. in Belgium)

  • "Research Based Pharma Companies in Austerity Times" - Dr. Bruno Strigini (President Europe/Canada, Merck & Co., Inc./MSD)
  • "The Pharma Sector after the Econoshock" - Geert Noels (Chief Economist & CEO Econopolis)

18:00 – 19:00

30 years Galenus – Award Ceremony – Plenary Room

In association with Artsenkrant / Le Journal du médecin

Chair : Prof. Dr. Leo Neels (CEO pharma.be)

  • "Opening address and Award Ceremony" - Prime Minister Elio Di Rupo
  • "Presentation of the jury’s conclusions concerning the award winning innovative medicine" - Prof. Jean-Marc Kaufman (Full professor and chair of the department of Internal Medicine Ghent University and Chair of Endocrinology and Laboratory for Hormonology Ghent University Hospital)
  • Presentation by the award winning company
  • Presentation by a member of the Galenus jury of the Award winning young scientist
  • "30 jaar jury-werking Belgische Galenus prijs – 30 ans de jury prix Gallien Belge" – Prof. Em. Dr. Arnold G. Herman

19:00 – 20:30

Cocktail & networking – Exhibition Lounge

 
 

 
 

click here to register

  • Home
  • Contact Us
  • Disclaimer
  • Legal
made by Emakina